Pyongyang, August 26 (KCNA) — The tetrodocain injection produced by the Korea Jangsaeng Joint Venture Company is drawing attention of people for its mysterious efficacy.
Choe Hui Gyong, a section chief of the company, told that tetrodocain has proved highly efficacious for various kinds of chronic diseases through clinical trials over the last few decades. The demand for it is ever increasing, he said.
When it is applied, anesthesia comes quickly and lasts long. It has no after-effect.
It is efficacious for pain from cancer of the last stage, contusion, neuralgia, rheumatic arthritis, geriatric diseases, malignant influenza, bronchial asthma, bronchial inflammation, pneumonia, pharyngitis, splenitis and respiratory diseases. It is also good for the treatment of nose, pharynx, gullet and other cancers.
Its efficacy is 80 percent.
The injection can be used as anti-virus and anti-tuberculosis medicine to kill viruses in organic body including AIDS and SARC.
It also helps detoxicates narcotic poisoning.
Image credit: https://www.flickr.com/photos/28705377@N04/4611090102/